Isaac Francis

Regal Partners (ASX:RPL) has greenlit an on-market share buy-back program, signaling strong confidence in its financial trajectory.

Celsius Resources (ASX:CLA) said the Mines and Geosciences Bureau has approved the first renewal of Exploration Permit No. 011-2023-CAR for the Botilao Porphyry Copper-Gold prospect.

Mammoth Minerals (ASX:M79) has launched a new phase of reverse circulation drilling at its Excelsior Gold Project in Nevada.

Fintech lender Plenti Group (ASX:PLT) appointed Selena Verth as its CFO, effective July 1.

Neuren Pharmaceuticals (ASX:NEU) secures FDA feedback for NNZ-2591, validating its HIE study path and Pitt Hopkins trial endpoints for a 2026 launch.

Alphabet (NASDAQ:GOOGL) reported fourth-quarter results that handily beat Wall Street expectations, as the search giant proved that its heavy investments in generative AI are beginning to pay off through resurgent advertising growth and a surging cloud business.

IDEX (NYSE:IEX) reported fourth-quarter results that cleared Wall Street hurdles, fueled by robust demand for its mission-critical fluidics and life science components, though its initial 2026 outlook suggested a cautious start to the new year.

Reynolds Consumer Products (NASDAQ:REYN) reported fourth-quarter results that demonstrated the resilience of its "essentials" portfolio, as market share gains in its trash bag business helped offset a steep decline in foam tableware sales.

Fortive (NYSE:FTV) capped a transformative year by beating its own profit forecasts and rewarding shareholders with a massive $1.3 billion stock buyback program, as the company enters its first full year as a more focused industrial technology player.

Eli Lilly (NYSE:LLY) delivered a blowout fourth-quarter report and a massive 2026 forecast that solidified its position as the world’s most valuable healthcare company, fueled by the explosive growth of its tirzepatide franchise.